ALCOA+ & Data Integrity for Regulated Content

Operationalize ALCOA+ for Regulated Content Across the Lifecycle with ALCOA+ for regulated content

ALCOA+ for regulated content is the discipline of treating every authored regulatory document — labeling, clinical, CMC, medical, and safety — as an inspection-grade record subject to the same data integrity expectations health authorities apply to laboratory and manufacturing data. ALCOA+ for regulated content is the data integrity standard that health authorities apply to any record used to support a regulatory decision.

The original five ALCOA principles — Attributable, Legible, Contemporaneous, Original, and Accurate — were extended to ALCOA+ for regulated content with four additional attributes (Complete, Consistent, Enduring, Available), and further to ALCOA++ with the explicit addition of Traceable, as set out in current guidance from WHO, FDA, and MHRA . In pharma, regulated content is a record. Labeling, clinical, CMC, medical, and safety documents all carry the same evidentiary weight as laboratory or manufacturing data.

Document-centric authoring introduces data integrity gaps that are structural, not procedural. Docuvera operationalizes ALCOA+ at the component level, so attribution, timestamps, sources of truth, and audit trails are architectural properties of the content, not afterthoughts added at review. This is data integrity by design for pharma regulated content — the same governance posture FDA expects under 21 CFR Part 11 and EU regulators expect under EU GMP Annex 11, applied at the authoring layer rather than bolted on at submission.